Navigation Links
Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America
Date:6/17/2013

ST. PAUL, Minn., June 17, 2013 /PRNewswire/ -- Prime Therapeutics, in collaboration with public relations agency, Weber Shandwick, and branding and design agency, Larsen, was awarded the Silver Anvil for its internal communication campaign "Millions of Reasons, One Purpose, Repositioning Prime Therapeutics." The award was presented at the Public Relations Society of America (PRSA) 2013 Silver Anvil Awards Ceremony held June 13 at the AXA Equitable Center in New York.

The Silver Anvil, which has been presented annually since 1946, is the oldest and one of the most prestigious awards competitions for outstanding achievement in public relations, based on its rigorous judging criteria and emphasis on measurement and evaluation.

"This Silver Anvil award recognizes work we undertook to simplify and redefine our purpose statement to clearly reflect the important work we do to help people get the medicine they need to feel better and live well," said Michael Showalter, chief marketing officer at Prime. "Our employees have embraced this new purpose statement because it focuses on the people we truly serve."

PRSA, which is based in New York, is the largest professional organization serving the U.S. public relations community. With a mission to "advance the profession and the professional," PRSA provides news and information, thought leadership, continuing education and networking opportunities. It also sets standards of professional excellence and advocates for the business value of public relations.

About Prime Therapeutics
Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime manages pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and delivers medicine to members, offering clinical services for people with complex medical conditions. Headquartered in St. Paul, Minn., Prime serves nearly 20 million people. It is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Prime has been recognized as one of the fastest-growing private companies in the nation. 

For more information, visit www.primetherapeutics.com or follow @Prime_PBM on Twitter.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tras el exitoso lanzamiento en Estados Unidos, el nuevo Simbionix U/S Mentor se introducirá por primera vez en Europa
2. Prime Therapeutics receives highest rating in 2013 customer satisfaction survey
3. Prime Therapeutics specialty pharmacy receives URAC accreditation
4. Zydus Demonstra Pioneirismo com o Inovador LIPAGLYN, Primeiro NCE da Índia a Entrar no Mercado
5. Prime Therapeutics appoints Scott Fries as senior vice president of government programs
6. Primex Wireless Adds Differential Pressure Monitoring to IAQ lineup with Release of SNS Application Management Platform (AMP 4.0)
7. Journal of Managed Care Pharmacy recognizes Prime Therapeutics with two 2012 JMCP Award for Excellence Honorable Mentions
8. Sanomedics Signs Definitive Agreement to Acquire Prime Time Medical
9. PrimerLife.com celebra el aniversario del descubrimiento del ADN con una nueva red social
10. PrimerLife.com, a Skolkovo Participant Company, Celebrates Anniversary of DNA Discovery with Launch of New Social Network
11. Rockwell Medical Announces Iron Delivery Drug SFP Meets Primary Endpoint in PRIME Clinical Study Demonstrating Statistically Significant 37% Reduction in ESA Dose
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)...  The Corporate Whistleblower Center is urging ... anytime at 866-714-6466 if they possess proof a pharmaceutical company ... Aside from the innocent patients frequently being the victims, these types ... practices target Medicare recipients or the elderly. ... ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 According to ... in more than one-third (38%) of patients with non-small cell ... epidermal growth factor receptor (EGFR) genetic mutation status. The findings ... ( LBA ID #6067 #P3.02b ) at the ... Vienna, Austria . The survey results revealed ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 ... II trial in patients with unresectable malignant pleural ... survival (PFS). The data, presented at the 17 ... in Vienna , showed nintedanib ... to placebo plus pemetrexed/cisplatin, with a significantly improved ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... A quote from Dr. Edward ... comments on social media that offer a rare glimpse into the mind of those ... and New York Times bestselling author, has described people with ADHD as having “Ferrari ...
(Date:12/7/2016)... Hollywood, Fl (PRWEB) , ... December 07, 2016 , ... When it came time to ... new heart. Just 40 minutes later, the Pediatric Heart Transplant team at Joe ... true making the Weston teen the hospital’s 30th heart transplant recipient. , “He was ...
(Date:12/7/2016)... ... 07, 2016 , ... Baciocco Brothers Insurance Agency, a northern ... Sacramento/Folsom region, is initiating a charity event to raise support and awareness for ... treatment center in Sacramento works to provide area teens and families with treatment ...
(Date:12/7/2016)... ... December 07, 2016 , ... AlignLife clinics nationwide are giving ... are not fortunate enough to receive bountiful gifts wrapped tightly under a Christmas Tree. ... to the children of the world. , In exchange for generous donations, customers will ...
(Date:12/7/2016)... ... 2016 , ... Sharon Kleyne, host of the nationally syndicated radio program, The ... of America, declared on her radio program in November 2016 the need to educate ... bullies attack leaders in corporate America, they are trying to take advantage of successful ...
Breaking Medicine News(10 mins):